Search Results - "Giudice, Anna M"
-
1
CAR T-cell-mediated delivery of bispecific innate immune cell engagers for neuroblastoma
Published in Nature communications (21-08-2024)“…Novel chimeric antigen receptor (CAR) T-cell approaches are needed to improve therapeutic efficacy in solid tumors. High-risk neuroblastoma is an aggressive…”
Get full text
Journal Article -
2
GPC2 antibody–drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapies
Published in Journal for immunotherapy of cancer (01-12-2022)“…BackgroundAntibody–drug conjugates (ADCs) that deliver cytotoxic drugs to tumor cells have emerged as an effective and safe anticancer therapy. ADCs may induce…”
Get full text
Journal Article -
3
Targeting GPC2 on Intraocular and CNS Metastatic Retinoblastomas with Local and Systemic Delivery of CAR T Cells
Published in Clinical cancer research (15-08-2024)“…Retinoblastoma is the most common intraocular malignancy in children. Although new chemotherapeutic approaches have improved ocular salvage rates, novel…”
Get full text
Journal Article -
4
Abstract 5121: Next-generation immunocompetent and humanized neuroblastoma murine models for the discovery and validation of novel immunotherapies
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…The success of CD19-directed chimeric antigen receptor (CAR)-T cell therapy for ALL has yet to be matched in solid pediatric malignancies. Moreover, immune…”
Get full text
Journal Article -
5
Abstract 5118: Neuroblastoma extracellular vesicles present GPC2 and activate GPC2 CAR T cells in an antigen-dependent manner
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Glypican 2 (GPC2) chimeric antigen receptor (CAR) T cells are safe and efficacious in neuroblastoma and are currently being tested in a first-in-human Phase 1…”
Get full text
Journal Article